We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-22.77%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.72B
AUM Growth
-$1.36B
Cap. Flow
-$888M
Cap. Flow %
-51.56%
Top 10 Hldgs %
32.97%
Holding
299
New
73
Increased
48
Reduced
40
Closed
96

Top Buys

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$37.8M
2
GH icon
Guardant Health
GH
+$19.9M
3
LUNG icon
Pulmonx
LUNG
+$15.2M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$13.5M
5
LYRA
LYRA THERAPEUTICS INC
LYRA
+$11.2M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18M
2
CCCC icon
C4 Therapeutics
CCCC
+$15.2M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$13.5M
4
ICUI icon
ICU Medical
ICUI
+$12.8M
5
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
+$11.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.95%
2 Industrials 0.3%
3 Consumer Staples 0.27%
4 Materials 0.11%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALC icon
51
PUT
Alcon
ALC
$36.4B
$9.44M 0.55%
+135,000
New +$9.85M
APLS
52
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$9.04M 0.53%
200,000
– –
OLK
53
CALL
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$8.97M 0.52%
590,000
– –
OM icon
54
CALL
Outset Medical
OM
$90.6M
$8.89M 0.52%
+39,867
New +$17.2M
HCA icon
55
PUT
HCA Healthcare
HCA
$89.1B
$8.4M 0.49%
50,000
+30,000
+150% +$6.45M
ISRG icon
56
CALL
Intuitive Surgical
ISRG
$142B
$8.03M 0.47%
40,000
-35,500
-47% -$8.33M
KALV
57
DELISTED
KalVista Pharmaceuticals
KALV
$8M 0.46%
812,828
+771,435
+1,864% +$8.51M
ARKK icon
58
CALL
ARK Innovation ETF
ARKK
$6.38B
$7.98M 0.46%
+200,000
New +$9.52M
APYX icon
59
Apyx Medical
APYX
$127M
$7.75M 0.45%
1,323,303
+340,620
+35% +$1.75M
XNTK icon
60
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.22B
$7.37M 0.43%
99,200
-100,000
-50% -$11.6M
ALNY icon
61
PUT
Alnylam Pharmaceuticals
ALNY
$29.6B
$7.29M 0.42%
50,000
– –
PACB icon
62
PUT
Pacific Biosciences
PACB
$354M
$7.29M 0.42%
1,650,000
+300,000
+22% +$1.82M
QTRX icon
63
Quanterix
QTRX
$124M
$7.08M 0.41%
+437,500
New +$8.99M
EVH icon
64
Evolent Health
EVH
$464M
$7.06M 0.41%
230,000
+30,000
+15% +$874K
ISEE
65
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$7.02M 0.41%
729,600
+200,000
+38% +$2.51M
DXCM icon
66
PUT
DexCom
DXCM
$33.8B
$7.01M 0.41%
+94,000
New +$8.58M
ISEE
67
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$6.88M 0.4%
715,144
-150,000
-17% -$1.88M
IART icon
68
PUT
Integra LifeSciences
IART
$1.35B
$6.69M 0.39%
123,900
– –
OM icon
69
Outset Medical
OM
$90.6M
$6.59M 0.38%
29,580
-2,080
-7% -$895K
TRUP icon
70
PUT
Trupanion
TRUP
$1.34B
$6.57M 0.38%
109,000
-116,000
-52% -$7.9M
CERE
71
CALL
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$6.43M 0.37%
+243,400
New +$6.91M
NSTG
72
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
$6.35M 0.37%
+500,000
New +$9.31M
NVCR icon
73
PUT
NovoCure
NVCR
$2.06B
$6.25M 0.36%
90,000
+27,300
+44% +$2.06M
ABMD
74
PUT
DELISTED
Abiomed Inc
ABMD
$6.19M 0.36%
+25,000
New +$6.75M
TFX icon
75
PUT
Teleflex
TFX
$5.91B
$6.15M 0.36%
+25,000
New +$7.29M
1 2
3
4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q2 2022 Portfolio in Review

As of Q2 2022, Pura Vida Investments held 299 positions worth $1.72B, down 44% from $3.08B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Pura Vida Investments withdrew a net $888M in Q2 2022, closing 96 positions and reducing 40 holdings. Its most notable exit was C4 Therapeutics, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 24% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Pura Vida Investments opened a new position in Glaukos worth $36.2M.

  • Pura Vida Investments's largest Q2 2022 buy was Glaukos: 796,600 shares worth $36.2M.
  • Pura Vida Investments added most to Guardant Health in Q2 2022, an estimated $19.9M increase.
  • Pura Vida Investments's biggest Q2 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $18M.
  • Pura Vida Investments fully exited C4 Therapeutics in Q2 2022, selling an estimated $15.2M.
  • Pura Vida Investments's ten largest holdings make up 33% of its $1.72B portfolio in Q2 2022.
  • Pura Vida Investments opened 73 new positions and closed 96 in Q2 2022.
  • Pura Vida Investments's portfolio value fell 44% quarter-over-quarter to $1.72B.

Based on Pura Vida Investments's 13F filing for Q2 2022, filed 15 Aug 2022.